Stock Scorecard

Stock Summary for CollPlant Biotechnologies Ltd New (CLGN) - $3.67 as of 12/20/2024 3:22:58 PM EST

Total Score

10 out of 30

Safety Score

14 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CLGN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CLGN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CLGN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for CLGN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for CLGN (14 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 5
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 1
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 1
Price to Earnings (Max of 10) 0

Financial Details for CLGN

Company Overview
Ticker CLGN
Company Name CollPlant Biotechnologies Ltd New
Country USA
Description CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company is headquartered in Rehovot, Israel.
Sector Name LIFE SCIENCES
Industry Name ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History
Last Day Price 3.67
Price 4 Years Ago 10.77
Last Day Price Updated 12/20/2024 3:22:58 PM EST
Last Day Volume 16,599
Average Daily Volume 12,926
52-Week High 6.99
52-Week Low 3.31
Last Price to 52 Week Low 10.88%

Valuation Measures
Trailing PE N/A
Industry PE 33.78
Sector PE 40.44
5-Year Average PE -334.68
Free Cash Flow Ratio 2.74
Industry Free Cash Flow Ratio 27.25
Sector Free Cash Flow Ratio 27.17
Current Ratio Most Recent Quarter 5.38
Total Cash Per Share 1.34
Book Value Per Share Most Recent Quarter 2.48
Price to Book Ratio 2.51
Industry Price to Book Ratio 3.88
Sector Price to Book Ratio 20.63
Price to Sales Ratio Twelve Trailing Months 61.10
Industry Price to Sales Ratio Twelve Trailing Months 20.68
Sector Price to Sales Ratio Twelve Trailing Months 24.53
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics
Total Shares Outstanding 11,454,500
Market Capitalization 42,038,015
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 58.10%
Reported EPS 12 Trailing Months -1.53
Reported EPS Past Year -1.12
Reported EPS Prior Year -0.46
Net Income Twelve Trailing Months -17,420,000
Net Income Past Year -7,019,000
Net Income Prior Year -16,753,000
Quarterly Revenue Growth YOY -97.60%
5-Year Revenue Growth 18.01%
Operating Margin Twelve Trailing Months -17.69

Balance Sheet
Total Cash Most Recent Quarter 15,371,000
Total Cash Past Year 26,674,000
Total Cash Prior Year 29,653,000
Net Cash Position Most Recent Quarter 15,371,000
Net Cash Position Past Year 26,674,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 28,340,000
Total Stockholder Equity Prior Year 32,281,000
Total Stockholder Equity Most Recent Quarter 16,918,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months -13,627,000
Free Cash Flow Per Share Twelve Trailing Months -1.19
Free Cash Flow Past Year -3,717,000
Free Cash Flow Prior Year -15,014,000

Options
Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.12
MACD Signal -0.08
20-Day Bollinger Lower Band 3.44
20-Day Bollinger Middle Band 4.43
20-Day Bollinger Upper Band 5.43
Beta 0.48
RSI 41.12
50-Day SMA 5.02
150-Day SMA 6.91
200-Day SMA 9.29

System
Modified 12/20/2024 9:07:01 PM EST